Sign in

CIK 0001645469 · Non-accelerated filer<br>Smaller reporting company

Monopar Therapeutics

Sign in to watch
Ticker
MNPR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
320463781
Phone
8473880349
Business address
1000 SKOKIE BLVD SUITE 350, WILMETTE, IL, 60091
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$5,335,315
in 9 filings, $5.3M under 10b5-1 plans

Net −$5,335,315. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Robinson Chandler −$2.6M Chief Executive Officer sold 23% of stake
  2. Tsuchimoto Kim R −$1.2M Director sold 100% of stake
  3. Anderson Raymond −$918K Director sold 64% of stake
  4. STARR CHRISTOPHER M −$659K Director sold 62% of stake
  5. RIOUX PATRICE −$111 Acting Chief Medical Officer sold <1% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-03-04 Robinson Chandler Chief Executive Officer Shares withheld for taxes −1,759 $31.70 $56K 63,091
2025-03-04 Robinson Chandler Chief Executive Officer Grant or award · Stock Options +85,759 85,759
2025-03-04 Robinson Chandler Chief Executive Officer Grant or award · Restricted Stock Units +79,899 104,777
2025-03-04 Robinson Chandler Chief Executive Officer Option exercise · Restricted Stock Units −6,002 98,775
2025-03-04 Cittadine Andrew Chief Operating Officer Grant or award · Stock Options +43,445 43,445
2025-03-04 Cittadine Andrew Chief Operating Officer Grant or award · Restricted Stock Units +40,581 51,655
2025-03-04 STARR CHRISTOPHER M Director Grant or award · Stock Options +11,365 11,365
2025-03-04 KLAUSNER ARTHUR J Director Grant or award · Stock Options +11,365 11,365
2025-03-04 Anderson Raymond Director Grant or award · Stock Options +11,365 11,365
2025-03-04 Talukdar Lavina Director Grant or award · Stock Options +5,683 5,683
2025-03-04 Tsuchimoto Kim R Director Grant or award · Stock Options +11,365 11,365
2025-03-03 Vu Quan Anh Chief Financial Officer Grant or award · Stock Options +25,000 25,000
2025-01-28 Robinson Chandler Chief Executive Officer Other acquisition +62,815 62,815
2025-01-01 RIOUX PATRICE Acting Chief Medical Officer Grant or award · Stock Options +2,000 2,000
2024-12-31 Cittadine Andrew Chief Operating Officer Option exercise +1,790 41,659
2024-12-31 Cittadine Andrew Chief Operating Officer Shares withheld for taxes −721 $22.00 $16K 40,938
2024-12-31 Cittadine Andrew Chief Operating Officer Option exercise · Restricted Stock Units −1,790 11,074
2024-12-31 Robinson Chandler Chief Executive Officer Option exercise +4,895 61,057
2024-12-31 Robinson Chandler Chief Executive Officer Shares withheld for taxes −2,209 $22.00 $49K 58,848
2024-12-31 Robinson Chandler Chief Executive Officer Option exercise · Restricted Stock Units −4,895 24,879

Page 8 of 14 · 265 trades